Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/12/09 |
Seattle
|
|
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Dendreon Burns $28M in Q3
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
Dendreon Recruits Genentech CEO, Former Lilly Manufacturing Chief to Board
|
Luke Timmerman |
10/09/09 |
Seattle
|
|
Dendreon to Turn in Provenge Application to FDA in Mid-November
|
Luke Timmerman |
09/24/09 |
Seattle
|
|
Five Big Questions For Dendreon’s Analyst Day
|
Luke Timmerman |
09/24/09 |
Seattle
|
|
How Did Calypso Raise $50M? The Story Behind Seattle’s Biggest VC Deal of 2009
|
Luke Timmerman |
09/18/09 |
Seattle
|
|
Calypso Medical Raises $50M to Strengthen Pinpointed Radiation Therapy for Cancer
|
Luke Timmerman |
09/17/09 |
Seattle
|
|
Dendreon Ends June with $287M Cash
|
Luke Timmerman |
08/11/09 |
Seattle
|
|
Dendreon Will Build Manufacturing Plant in Georgia
|
Eric Hal Schwartz |
08/10/09 |
Seattle
|
|
OncoGenex, Toiling in Dendreon’s Shadow, Scopes Out Partners For Prostate Cancer Drug
|
Luke Timmerman |
08/05/09 |
Seattle
|
|
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2
|
Luke Timmerman |
07/28/09 |
Seattle
|
|
Calypso Forms Deal With Varian
|
Luke Timmerman |
07/24/09 |
Seattle
|
|
Augmenix Raises Cash
|
Luke Timmerman |
07/23/09 |
Boston
|
|
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/23/09 |
Seattle
|
|
Dendreon Scouts for Next Manufacturing Plant, Probably Far From Salmon and Evergreens
|
Luke Timmerman |
07/22/09 |
Seattle
|
|
OncoGenex Raises $9.5M
|
Luke Timmerman |
07/20/09 |
Seattle
|
|
Dendreon May Open Atlanta Plant
|
Eric Hal Schwartz |
07/17/09 |
Seattle
|
|
Dendreon Tames Short Sellers, Transforms Itself into Old-School Buy-and-Hold Stock
|
Luke Timmerman |
06/30/09 |
Seattle
|
|
Dendreon, Resisting Urge to Sell, Eyes Opportunity to Be Seattle’s Next Immunex
|
Luke Timmerman |
06/10/09 |
Seattle
|
|
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
OncoGenex Drug Helps Prostate Cancer Patients Live Longer in Small Study
|
Luke Timmerman |
05/30/09 |
Seattle
|
|
Aragon Pharma Raises $8M
|
Bruce V. Bigelow |
05/21/09 |
San Diego
|
|
Dendreon Drug Works, But Can It Manufacture Enough to Meet Demand?
|
Luke Timmerman |
05/20/09 |
Seattle
|
|
Dendreon and Cell Therapeutics Sell Stock, Microsoft Buys BigPark, Calistoga Raises $30M, & More Seattle-Area Deals News
|
Gregory T. Huang |
05/12/09 |
Seattle
|
|
Dendreon Raises $197M in Stock Offering
|
Luke Timmerman |
05/11/09 |
Seattle
|
|
Tokai Pharma Reports $22M Round, Developing Drug for Prostate Cancer
|
Ryan McBride |
05/07/09 |
Boston
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
Dendreon Plans to Raise Cash for Manufacturing, Marketing
|
Luke Timmerman |
05/06/09 |
Seattle
|
|
Dendreon Goes on Hiring Binge After Prostate Cancer Drug Boosts Survival
|
Luke Timmerman |
05/06/09 |
Seattle
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
